계명대학교 의학도서관 Repository

Erratum : COVID-19 유행 시기의 성인 염증성 장질환 임상 진료지침: 전문가 합의 권고문

Metadata Downloads
Author(s)
Yong Eun ParkYoo Jin LeeJi Young ChangHyun Joo SongDuk Hwan KimYoung Joo YangByung Chang KimJae Gon LeeHee Chan YangMiyoung ChoiSeong-Eun KimSeung-Jae Myung
Keimyung Author(s)
Lee, Yoo Jin
Department
Dept. of Internal Medicine (내과학)
Journal Title
Korean J Gastroenterol
Issued Date
2021
Volume
78
Issue
3
Abstract
대한소화기학회지에 게재된 위 논문에서 초록을 정정합니다.
This correction is being published to correct the abstract in above article.

Before correction:
The coronavirus disease 2019 (COVID-19) pandemic has reduced the ability to prevent or control chronic disease due to the concerns about safety in accessing health care. Inflammatory bowel disease (IBD) is a chronic condition requiring long- term sustained treatment, which is difficult in the current panedemic situation. The Korean Association for the Study of Intestinal Diseases (KASID) has developed an expert consensus statement on the clinical practice management of adult inflammatory bowel disease during the COVID-19 pandemic. This expert consensus statement is based on guidelines and clinical reports from several countries around the world. It provides recommendations to deal with the risk of COVID-19 and medication use in IBD patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and emphasizes the importance of right treatment approach to avoid worsening of the disease condition in IBD patients.

After correction:
Many unexpected problems have resulted from the unprecedented COVID-19 pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients. This statement emphasizes that IBD is not a risk factor for COVID-19, and care should be taken not to exacerbate IBD in patients in remission state by maintaining their medications, except for corticosteroids.
Alternative Title
KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
Keimyung Author(s)(Kor)
이유진
Publisher
School of Medicine (의과대학)
Citation
Yong Eun Park et al. (2021). Erratum : COVID-19 유행 시기의 성인 염증성 장질환 임상 진료지침: 전문가 합의 권고문. Korean J Gastroenterol, 78(3), 202–203. doi: 10.4166/kjg.2021.78.3.202
Type
Article
ISSN
2233-6869
Source
https://www.kjg.or.kr/journal/view.html?uid=5752&vmd=Full
DOI
10.4166/kjg.2021.78.3.202
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43771
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.